Amyloid-β oligomers transiently inhibit AMP-activated kinase and cause metabolic defects in hippocampal neurons

AMP-activated kinase (AMPK) is a key player in energy sensing and metabolic reprogramming under cellular energy restriction. Several studies have linked impaired AMPK function to peripheral metabolic diseases such as diabetes. However, the impact of neurological disorders, such as Alzheimer disease (AD), on AMPK function and downstream effects of altered AMPK activity on neuronal metabolism have been investigated only recently. Here, we report the impact of Aβ oligomers (AβOs), synaptotoxins that accumulate in AD brains, on neuronal AMPK activity. Short-term exposure of cultured rat hippocampal neurons or ex vivo human cortical slices to AβOs transiently decreased intracellular ATP levels and AMPK activity, as evaluated by its phosphorylation at threonine residue 172 (AMPK-Thr(P)172). The AβO-dependent reduction in AMPK-Thr(P)172 levels was mediated by glutamate receptors of the N-methyl-d-aspartate (NMDA) subtype and resulted in removal of glucose transporters (GLUTs) from the surfaces of dendritic processes in hippocampal neurons. Importantly, insulin prevented the AβO-induced inhibition of AMPK. Our results establish a novel toxic impact of AβOs on neuronal metabolism and suggest that AβO-induced, NMDA receptor-mediated AMPK inhibition may play a key role in early brain metabolic defects in AD.

[1]  Zhuhao Wu,et al.  GLUT4 Mobilization Supports Energetic Demands of Active Synapses , 2017, Neuron.

[2]  J. Fuentealba,et al.  ATP leakage induces P2XR activation and contributes to acute synaptic excitotoxicity induced by soluble oligomers of β-amyloid peptide in hippocampal neurons , 2016, Neuropharmacology.

[3]  H. van Praag,et al.  Exercise-mimetic AICAR transiently benefits brain function , 2015, Oncotarget.

[4]  S. Ferreira,et al.  Neuronal stress signaling and eIF2α phosphorylation as molecular links between Alzheimer's disease and diabetes , 2015, Progress in Neurobiology.

[5]  J. Laks,et al.  d-serine levels in Alzheimer's disease: implications for novel biomarker development , 2015, Translational Psychiatry.

[6]  Weikun Guo,et al.  Astrocytic adenosine receptor A2A and Gs-coupled signaling regulate memory , 2014, Nature Neuroscience.

[7]  Brian C Coe,et al.  Alzheimer's Disease-Like Pathology Induced by Amyloid-β Oligomers in Nonhuman Primates , 2014, The Journal of Neuroscience.

[8]  B. Viollet,et al.  Inhibition of AMP-Activated Protein Kinase Signaling Alleviates Impairments in Hippocampal Synaptic Plasticity Induced by Amyloid β , 2014, The Journal of Neuroscience.

[9]  L. Boulanger,et al.  MHC Class I Limits Hippocampal Synapse Density by Inhibiting Neuronal Insulin Receptor Signaling , 2014, The Journal of Neuroscience.

[10]  S. Ferreira,et al.  How does brain insulin resistance develop in Alzheimer's disease? , 2014, Alzheimer's & Dementia.

[11]  S. Ferreira,et al.  Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease , 2014, Alzheimer's & Dementia.

[12]  D. Munoz,et al.  TNF-α mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer's β-amyloid oligomers in mice and monkeys. , 2013, Cell metabolism.

[13]  S. Lipton,et al.  Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss , 2013, Proceedings of the National Academy of Sciences.

[14]  W. Klein,et al.  Memantine Rescues Transient Cognitive Impairment Caused by High-Molecular-Weight Aβ Oligomers But Not the Persistent Impairment Induced by Low-Molecular-Weight Oligomers , 2013, The Journal of Neuroscience.

[15]  F. Polleux,et al.  The CAMKK2-AMPK Kinase Pathway Mediates the Synaptotoxic Effects of Aβ Oligomers through Tau Phosphorylation , 2013, Neuron.

[16]  F. D. De Felice.  Alzheimer's disease and insulin resistance: translating basic science into clinical applications. , 2013, The Journal of clinical investigation.

[17]  Ali Haeri,et al.  Insulin in the Brain: Sources, Localization and Functions , 2013, Molecular Neurobiology.

[18]  M. Tuszynski,et al.  JNK3 Perpetuates Metabolic Stress Induced by Aβ Peptides , 2012, Neuron.

[19]  S. Craft.  Alzheimer disease: Insulin resistance and AD—extending the translational path , 2012, Nature Reviews Neurology.

[20]  J. Koh,et al.  Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β. , 2012, Human molecular genetics.

[21]  G. Ronnett,et al.  AMP-Activated Protein Kinase (AMPK) and Energy-Sensing in the Brain , 2012, Experimental neurobiology.

[22]  I. Mook‐Jung,et al.  Aβ-induced formation of autophagosomes is mediated by RAGE-CaMKKβ-AMPK signaling , 2012, Neurobiology of Aging.

[23]  Cindee M. Madison,et al.  Cerebrovascular disease, beta-amyloid, and cognition in aging , 2012, Neurobiology of Aging.

[24]  D. Munoz,et al.  An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers. , 2012, The Journal of clinical investigation.

[25]  I. Torres-Aleman,et al.  The many faces of insulin-like peptide signalling in the brain , 2012, Nature Reviews Neuroscience.

[26]  H. Brentani,et al.  Amyloid-β Oligomers Induce Differential Gene Expression in Adult Human Brain Slices* , 2012, The Journal of Biological Chemistry.

[27]  B. Gerton,et al.  Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. , 2012, Archives of neurology.

[28]  R. Schiffmann,et al.  Early Alterations of Brain Cellular Energy Homeostasis in Huntington Disease Models* , 2011, The Journal of Biological Chemistry.

[29]  D. Selkoe.  Resolving controversies on the path to Alzheimer's therapeutics , 2011, Nature Medicine.

[30]  D. Dickson,et al.  Nuclear translocation of AMPK-α1 potentiates striatal neurodegeneration in Huntington’s disease , 2011, The Journal of cell biology.

[31]  D. Selkoe,et al.  Soluble amyloid β-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration , 2011, Proceedings of the National Academy of Sciences.

[32]  David Carling,et al.  AMP-activated protein kinase (AMPK) is a tau kinase, activated in response to amyloid β-peptide exposure. , 2011, The Biochemical journal.

[33]  C. Hetz,et al.  Amyloid β-peptide oligomers stimulate RyR-mediated Ca2+ release inducing mitochondrial fragmentation in hippocampal neurons and prevent RyR-mediated dendritic spine remodeling produced by BDNF. , 2011, Antioxidants & redox signaling.

[34]  D. Dickson,et al.  AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer’s disease and other tauopathies , 2011, Acta Neuropathologica.

[35]  W. Klein,et al.  Amyloid-β Triggers the Release of Neuronal Hexokinase 1 from Mitochondria , 2010, PloS one.

[36]  W. Klein,et al.  N‐Methyl‐d‐aspartate receptors are required for synaptic targeting of Alzheimer’s toxic amyloid‐β peptide oligomers , 2010, Journal of neurochemistry.

[37]  E. Cavalheiro,et al.  Activation of D1/D5 Dopamine Receptors Protects Neurons from Synapse Dysfunction Induced by Amyloid-β Oligomers* , 2010, The Journal of Biological Chemistry.

[38]  G. Taglialatela,et al.  Amyloid‐β oligomers impair fear conditioned memory in a calcineurin‐dependent fashion in mice , 2010, Journal of neuroscience research.

[39]  E. Kraegen,et al.  Downregulation of AMPK Accompanies Leucine- and Glucose-Induced Increases in Protein Synthesis and Insulin Resistance in Rat Skeletal Muscle , 2010, Diabetes.

[40]  S. Ferreira,et al.  Amyloid-β Peptide Oligomers Disrupt Axonal Transport through an NMDA Receptor-Dependent Mechanism That Is Mediated by Glycogen Synthase Kinase 3β in Primary Cultured Hippocampal Neurons , 2010, The Journal of Neuroscience.

[41]  Jun Ren,et al.  Overnutrition and maternal obesity in sheep pregnancy alter the JNK‐IRS‐1 signaling cascades and cardiac function in the fetal heart , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[42]  W. Klein,et al.  A Mouse Model of Amyloid β Oligomers: Their Contribution to Synaptic Alteration, Abnormal Tau Phosphorylation, Glial Activation, and Neuronal Loss In Vivo , 2010, The Journal of Neuroscience.

[43]  R. Trullas,et al.  Amyloid beta oligomers induce Ca2+ dysregulation and neuronal death through activation of ionotropic glutamate receptors. , 2010, Cell calcium.

[44]  Tara Spires-Jones,et al.  Amyloid β Induces the Morphological Neurodegenerative Triad of Spine Loss, Dendritic Simplification, and Neuritic Dystrophies through Calcineurin Activation , 2010, The Journal of Neuroscience.

[45]  Isidro Ferrer,et al.  Mitochondrial ATP‐Synthase in the Entorhinal Cortex Is a Target of Oxidative Stress at Stages I/II of Alzheimer's Disease Pathology , 2010, Brain pathology.

[46]  Xiaohua Douglas Zhang,et al.  Inhibition of Calcineurin-mediated Endocytosis and α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors Prevents Amyloid β Oligomer-induced Synaptic Disruption , 2009, The Journal of Biological Chemistry.

[47]  C. Grillo,et al.  Insulin-stimulated translocation of GLUT4 to the plasma membrane in rat hippocampus is PI3-kinase dependent , 2009, Brain Research.

[48]  B. Kemp,et al.  AMPK in Health and Disease. , 2009, Physiological reviews.

[49]  Gaochao Zhou,et al.  AMPK: an emerging drug target for diabetes and the metabolic syndrome. , 2009, Cell metabolism.

[50]  F. Di Virgilio,et al.  Activation of Microglia by Amyloid β Requires P2X7 Receptor Expression1 , 2009, The Journal of Immunology.

[51]  W. Klein,et al.  Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of Aβ oligomers , 2009, Proceedings of the National Academy of Sciences.

[52]  D. Selkoe,et al.  A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease. , 2009, Archives of neurology.

[53]  E. Bigio,et al.  Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers , 2008, Neurobiology of Aging.

[54]  K. Ashe,et al.  Plaque-bearing mice with reduced levels of oligomeric amyloid-β assemblies have intact memory function , 2008, Neuroscience.

[55]  P. Mehta,et al.  Intranasal insulin improves cognition and modulates β-amyloid in early AD , 2008, Neurology.

[56]  I. Grundke‐Iqbal,et al.  Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease , 2008, FEBS letters.

[57]  Jun Li,et al.  Neuroprotective Effects of Adenosine Monophosphate-Activated Protein Kinase Inhibition and Gene Deletion in Stroke , 2007, Stroke.

[58]  W. Klein,et al.  Aβ Oligomers Induce Neuronal Oxidative Stress through an N-Methyl-D-aspartate Receptor-dependent Mechanism That Is Blocked by the Alzheimer Drug Memantine* , 2007, Journal of Biological Chemistry.

[59]  F. Thong,et al.  The Rab GTPase-Activating Protein AS160 Integrates Akt, Protein Kinase C, and AMP-Activated Protein Kinase Signals Regulating GLUT4 Traffic , 2007, Diabetes.

[60]  F. Metzger,et al.  Disturbed Cross Talk between Insulin-Like Growth Factor I and AMP-Activated Protein Kinase as a Possible Cause of Vascular Dysfunction in the Amyloid Precursor Protein/Presenilin 2 Mouse Model of Alzheimer's Disease , 2007, The Journal of Neuroscience.

[61]  E. Bigio,et al.  Monoclonal antibodies that target pathological assemblies of Aβ , 2007, Journal of neurochemistry.

[62]  C. Oliveira,et al.  Insulin Restores Metabolic Function in Cultured Cortical Neurons Subjected to Oxidative Stress , 2006, Diabetes.

[63]  L. Schäffer,et al.  Hybrid Receptors Formed by Insulin Receptor (IR) and Insulin-like Growth Factor I Receptor (IGF-IR) Have Low Insulin and High IGF-1 Affinity Irrespective of the IR Splice Variant* , 2006, Journal of Biological Chemistry.

[64]  S. Ferreira,et al.  Activation of GABAA receptors by taurine and muscimol blocks the neurotoxicity of β-amyloid in rat hippocampal and cortical neurons , 2005, Neuropharmacology.

[65]  P. Livrea,et al.  Soluble β-Amyloid1-40 Induces NMDA-Dependent Degradation of Postsynaptic Density-95 at Glutamatergic Synapses , 2005, The Journal of Neuroscience.

[66]  M. Portero-Otín,et al.  Proteins in Human Brain Cortex Are Modified by Oxidation, Glycoxidation, and Lipoxidation , 2005, Journal of Biological Chemistry.

[67]  Á. Almeida,et al.  Inhibition of mitochondrial respiration by nitric oxide rapidly stimulates cytoprotective GLUT3-mediated glucose uptake through 5'-AMP-activated protein kinase. , 2004, The Biochemical journal.

[68]  J. D. Figueroa-Villar,et al.  Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Aβ oligomerization , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[69]  M. Mattson.  Pathways towards and away from Alzheimer's disease , 2004, Nature.

[70]  S. Hoyer.  Glucose metabolism and insulin receptor signal transduction in Alzheimer disease. , 2004, European journal of pharmacology.

[71]  C. Finch,et al.  Alzheimer's disease-affected brain: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[72]  C. Culmsee,et al.  AMP-activated protein kinase is highly expressed in neurons in the developing rat brain and promotes neuronal survival following glucose deprivation , 2001, Journal of Molecular Neuroscience.

[73]  T. Morgan,et al.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[74]  W. Honer,et al.  Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease , 1994, Annals of neurology.

[75]  A. Ullrich,et al.  Receptors for insulin and insulin-like growth factor-I can form hybrid dimers. Characterisation of hybrid receptors in transfected cells. , 1990, The Biochemical journal.

[76]  T. Montine,et al.  Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment A Pilot Clinical Trial , 2011 .

[77]  D. Hardie,et al.  AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. , 2005, Cell metabolism.

[78]  E. King,et al.  The colorimetric determination of phosphorus. , 1932, The Biochemical journal.